Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity

Fatigue, QoL, and work and activity impairment improved following dupilumab initiation, though most patients did not achieve clinically relevant improvements. Effects on fatigue and work and activity impairment appear less pronounced compared with asthma symptom control, possibly due to irreversible impairments in some patients.

Authors

Institutions

Publication Details

Journal
The Journal of Allergy and Clinical Immunology In Practice
Published
2025-11-21
DOI
https://doi.org/10.1016/j.jaip.2025.11.015
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity

Anneke Ten Brinke, Simone Hashimoto, Jacob K. Sont, Arnoud F Aldenkamp et al.
The Journal of Allergy and Clinical Immunology In Practice
Dermatology and Skin Diseases
article

Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity

Anneke Ten Brinke, Simone Hashimoto, Jacob K. Sont, Arnoud F Aldenkamp, Astrid van Huisstede, Jeroen M.A.M. Retera, Marijke Amelink, Kim de Jong, Karen T.M. Oud, Johannes A. Kroes, Fleur L. Meulmeester, Thomas Macken, Kornelis W. Patberg, Karin B. Fieten, Gert‐Jan Braunstahl, Els J.M. Weersink, L. Havé, Annelies Beukert, Edwin van Velzen, Lennart Conemans, Marjo J.T. van de Ven, Sarah Bendien, Ilonka H. van Veen, Pieter-Paul Hekking, Lotte van Ruitenbeek
article en

Abstract

Fatigue, QoL, and work and activity impairment improved following dupilumab initiation, though most patients did not achieve clinically relevant improvements. Effects on fatigue and work and activity impairment appear less pronounced compared with asthma symptom control, possibly due to irreversible impairments in some patients.

The Journal of Allergy and Clinical Immunology In PracticeVol. 14(3)
Radboud University Nijmegen (NL), Fryske Akademy (NL), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Medisch Spectrum Twente (NL), Medisch Centrum Leeuwarden (NL), Maastricht University (NL), Sint Franciscus Gasthuis (NL), Spaarne Ziekenhuis (NL), Northwest Hospital (US), Amsterdam Neuroscience (NL), Ziekenhuis Gelderse Vallei (NL), Nederlands Astmacentrum Davos (CH), Haga Hospital (NL), Isala (NL), Elisabeth-TweeSteden Ziekenhuis (NL), Ziekenhuis Groep Twente (NL), Franciscus Vlietland (NL), Amsterdam University Medical Centers (NL), Rijnstate Hospital (NL), Deventer Ziekenhuis (NL), Meander Medisch Centrum (NL), Jeroen Bosch Ziekenhuis (NL), Amsterdam University of Applied Sciences (NL), University of Amsterdam (NL)
AstraZeneca, Sanofi, Teva Pharmaceutical Industries, European Respiratory Society, ZonMw
Openalex Percentile: Top 41%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.